Efferocytosis in cancer: when "clean-up" cells help tumours hide

Every day, billions of cells in your body reach the end of their lives and quietly self-destruct. The mess they leave behind is cleared away by macrophages through a process called efferocytosis — literally, “the eating of the dead.” Done well, it is one of the most underappreciated feats of biological housekeeping: it removes potentially toxic debris while actively signalling to the rest of the immune system that all is calm, no inflammation required.

That calming signal is exactly the problem in cancer. Tumours are chaotic places where cells die constantly, and the macrophages that arrive to clean up are nudged into an anti-inflammatory, tissue-repair mode. In effect, the tumour borrows the body’s own “nothing to see here” program to switch off the very immune response that might otherwise destroy it.

Researchers are now asking whether we can flip that switch — blocking the receptors macrophages use to recognise dying cells, so that clearing the debris becomes an immunostimulatory event instead of a silencing one. Early preclinical work targeting molecules like MerTK and the “don’t-eat-me” signal CD47 suggests the strategy can re-awaken anti-tumour immunity. The trick, as always in immunology, is doing it in the tumour without unleashing inflammation everywhere else.